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How do we understand depression in people with persistent pain? 
 
Abstract 
Depression and depressed mood are common in people with persistent (chronic) pain, 
exacerbating disability and worsening quality of life. Yet the relationship between persistent 
pain and depression remains unclear, despite its importance for designing or adapting 
interventions to address both pain and depression.  
Meta-analysis of cognitive and behavioral interventions designed for rehabilitation of 
persistent pain shows small benefits for distress. However, substantial variation between 
studies in patients’ baseline levels of depression and in quality of treatments militates 
against any clear conclusions. Apart from these interventions, longitudinal studies on 
chronic pain and depression in adults from clinical populations provide weak evidence that 
depression worsens pain outcomes.  
We systematically searched for and reviewed 14 longitudinal studies that explored the 
association between persistent pain and depression, aiming to identify: (1) the effects on 
pain of baseline depression; (2) the effects on depression of baseline pain; and (3) possible 
mediating variables, with particular attention to methodology. Unfortunately, most studies 
used unsuitable instruments to measure depression, and we could draw only tentative 
conclusions about effects over time. Better models and clearer measurement strategies are 
required for a next generation of clinically useful treatment trials and, meanwhile, some 
implications for treatment are explored. 
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Introduction 
Depression, and depressed mood, are common problems in people with persistent pain 
(Banks & Kerns, 1996). Several theories have attempted to explain why persistent pain and 
depression occur together, using psychiatric nosology and conceptualizing them as two 
separate conditions; other theories suggest that pain and depression are indivisible. Many 
of these rely on cross-sectional studies which cast little light on the nature of the postulated 
association. We chose to review longitudinal studies of the relationships in an attempt to 
avoid this problem. 
Early theories that suggested conscious or unconscious transformation of distress into pain 
(psychosomatic) (e.g. Blumer and Heilbronn 1982) relied on perceived shortcomings in the 
medical evidence to assert the lack of any basis for pain. These are theoretically 
unsatisfactory, since persistent pain involves changes in the central nervous system, with or 
without overt structural evidence (Tracey and Mantyh 2007). Further, tests of the model 
have produced clear evidence against such an assertion (Turk and Salovey 1984; Merskey 
2000; Crombez et al. 2009).  Others proposed that depression caused pain or that pain 
caused depression (e.g. Fishbain et al. 1997), and epidemiological and cross-sectional 
studies were variously interpreted to support each, while the diathesis-stress model of 
Banks and Kerns (1996) straddled both. The diathesis-stress model suggested that 
individuals with increased sensitivity to particular stressors, either through genetic 
vulnerability or early adverse experiences, have an increased risk of developing depression, 
and that persistent pain is one such stressor because of its very persistence and its wide-
ranging effects.  
Biological models of depression in persistent pain, drawing on research with non-human 
animals, are largely overlooked in the human clinical literature on chronic pain treatment. 
One such model (Blackburn-Monro and Blackburn-Monro 2001) proposed moving away 
from the almost exclusive focus on neurotransmitters towards understanding persistent 
pain as a chronic inescapable stress, with resultant widespread effects via the hypothalamic-
pituitary-adrenal (HPA) axis. Another model (Schwartz et al. 2014), in mice with chronic 
inflammatory or neuropathic pain, described consistent and analgesic-resistant neuroplastic 
changes in the nucleus accumbens, decreasing motivation to work for a reward as the ratio 
of reward to response became progressively less favourable. A third, using mood induction 
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and pain stimulus on healthy human participants during functional magnetic resonance 
imaging (fMRI), showed clear effects of depressed mood, involving far more emotional 
processing of pain, with participants experiencing the pain stimulus as much more 
unpleasant (Berna et al. 2010). Such models tend to conceptualize depression as affect, 
neglecting cognitive processes (with the exception of Berna et al. 2010), as well as behaviors 
and symptoms (Pincus and Williams, 1999).  
More recently, Linton and Bergbom (2011) presented a model that includes a role for 
catastrophizing and emotion regulation in the relationship between persistent pain and 
depression. This model is described fully in the paper by Linton et al. (this volume). While it 
is a very considerable advance, using theories and evidence from both the pain field and 
mainstream psychology, it also risks under-recognising the extent to which persistent pain 
and depression are processed in common pathways and by shared neurotransmitter 
systems (Bair et al. 2003). In the last decade or so, evidence from neuroscience has provided 
a more specific basis for this emotion regulation model. The subject is too large for 
treatment here but studies of processing using imaging techniques (Bushnell et al. 2013; 
Tracey and Mantyh 2007) and using neurotransmitter balance and regulation (Bair et al. 
2003) provide mechanisms whereby mood influences the facilitation or inhibition of pain 
information from the periphery, and provides the context in which it is processed in systems 
and areas where emotion is also processed.  
Here we review longitudinal studies in clinical populations which examined the association 
between chronic pain and depression, addressing the following questions: 
1. Does depression affect pain and disability outcomes in patients with chronic pain? 
2. Does pain affect depression outcomes in treated or untreated depression? 
3. What variables mediate depression outcomes in chronic pain and depression at 
follow-up? 
 
Method 
Search strategy 
Given the thorough review by Bair et al. (2003), we searched from 2003 to 2013 in 
PsycINFO, MEDLINE, and reference lists of relevant papers, using the terms (modified as 
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appropriate per database): (depress*) or (low mood) combined with (chronic pain) or 
(subacute pain) or (sub-acute pain) or (acute to chronic pain) or (enduring pain) or (continual 
pain) or (sustained pain) (back pain), (musculoskeletal pain), (neck pain) and (shoulder pain). 
Studies were included in our review that: 1) were reported in a peer-reviewed journal; 2) 
were longitudinal; 3) tested an adult clinical population of whom at least 50% had sub-acute 
pain (4 weeks or longer) or chronic pain (3 months or longer) and/or depression; 5) assessed 
pain and depression at baseline and follow-up. We excluded studies focusing solely on 
treatment outcomes, or where chronic pain resulted from a specific disease process (e.g. 
cancer or rheumatoid arthritis).  
Methodological quality assessment 
The Newcastle-Ottawa Scale (NOS; Wells et al. 2000) was used  to assess the quality of 
studies and was adapted to meet the requirements of this review. It contains items on: (1) 
representativeness of the sample population, for which there were four levels, from truly 
representative of the average population to no description of the derivation of the cohort; 
(2) appropriate selection of the control cohort; control for gender and age; length of time 
between baseline and follow-up; adequacy of follow-up; and (3) appropriate assessment of 
persistent pain and depression at baseline and follow-up. We detailed these (for instance, 
defining six months as the minimum adequate follow-up period), and we paid particular 
attention to the measurement of depression, since almost all severity and diagnostic scales 
were developed and standardized on physically healthy populations. This makes the 
endorsement of particular items uninterpretable, in persistent pain populations where 
‘vegetative’ or somatic symptoms of depression are more often attributed by patients to 
persistent pain than to mood (Williams 1998; Morley et al. 2002; Hardt et al. 2000). The 
NOS awarded quality points for a sample size of more than 50 participants, time from 
baseline to follow-up greater than six months, fewer than 25% participants lost to follow-up 
and controlled for differences in participants lost to follow-up in the analyses. 
 
Results 
Overview of papers 
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In total, 2370 English language papers were identified after removal of duplicates. One 
hundred and ten from the search and one from references appeared from the abstract to be 
potentially eligible and were accessed as full papers. Of these, 97 were excluded for the 
following reasons, in descending order of frequency: not a clinical population; a treatment 
study; pain was related to a disease process; no pain or depression at baseline; not 
longitudinal; pain was acute at baseline; same data as in another eligible study (so only one 
was included); and duration of pain not specified. 
Of the 14 studies that met our criteria, methods of data collection varied from postal 
questionnaires to face-to-face interviews; and time between baseline and follow-up ranged 
from 2 months to 5 years. Sample recruitment and data collection methods are shown in 
Table 1. Studies were grouped according to whether they 1) included patients with chronic 
pain at baseline; 2) included patients with depression at baseline; or 3) focused on 
identifying variables that mediated outcomes in chronic pain and depression. 
 
1. Does depression at baseline affect pain and disability outcomes in chronic pain? 
Six studies of patients with chronic pain were found and were generally of good quality, 
except for problems of assessment of depression and pain. All studies recruited participants 
representative of the chronic pain population; controlled for age and gender in their 
analyses; had a sample size over 50; a follow-up over six months; and analysis of attrition 
where this was over 25%. The two studies with adequate methodology for assessment of 
depression (Dunn et al. 2008; Muller et al. 2013) reported that baseline depression in 
patients with chronic pain led to worse outcomes of pain and disability at follow-up. This 
finding agrees with several reviews (Bair et al. 2003; Banks & Kerns 1996; Fishbain et al. 
1997; Linton & Bergbom, 2011) that concluded with more confidence that depression at 
baseline leads to worse outcomes in chronic pain, though these used scales which 
confounded symptoms of depression and chronic pain. 
2. Does chronic pain at baseline affect depression outcomes in patients with treated or 
untreated depression? 
Three studies of moderate quality were found: their participants were representative of the 
chronic pain population; they controlled for gender and age in their analyses; sample size 
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was over 50; attrition was addressed in analyses. Two studies had follow-up periods over 6 
months. However, only one (Chung et al. 2012) used the most appropriate scale for 
depression, the Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith 1983); 
this study had a small sample and pain at baseline was relatively mild. It reported that pain 
severity and catastrophic thinking, but not anxiety and depression, predicted quality of life 
three months later.  
3. What variables mediate depression outcomes in chronic pain and depression at follow-
up? 
Six studies were found but these were of lower quality than those above. All but one 
recruited representative populations, but Van Liew et al. (2013) reported a large 
predominance of female participants. All but one (Rudich et al. 2010) had a sample size over 
50, and all addressed attrition in their analyses. Follow-up periods were mostly under 6 
months. The main problem was choice of scales for depression which risked inflation of 
scores on somatic symptomatology. The results of these studies suggested multiple possible 
mediators and several pathways leading to the development of depression in chronic pain 
but, given the likely overlap between measurement instruments, it is hard to determine 
whether associations were conceptually meaningful or indicated methodological 
shortcomings. 
 
Discussion 
Our systematic review and methodological considerations left a rather small sample of 
studies. Nevertheless, we have reasonable confidence in the finding that depression at 
baseline worsens pain and disability outcomes in people with chronic pain, when compared 
over six months or more. We found no clear evidence for pain at baseline worsening 
depression outcomes over the same time, and mediation models were too diverse to offer 
any distinct findings. 
Exclusion on the basis of what we judged unsatisfactory choices of measurement 
instruments, particularly for depression, left a rather small number of studies. Our position 
that these measurement instruments are inadequate remains a minority one, despite more 
than adequate demonstrations of a different dimensional structure of responses in the 
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presence of persistent pain (e.g. Pincus and Williams 1999, Morley et al. 2002) and even a 
somewhat separate somatic symptom dimension for several common depression 
instruments used in non-pain populations (Shafer 2006).  
Entirely different methodologies demonstrate that people with persistent pain are mainly, 
in their depressive thinking, preoccupied with their health (Pincus et al. 2007), and that in 
the focus of this preoccupation they differ from other populations with similar levels of 
depression (Rusu et al. 2012). The Rusu et al. study, using sentence completion (of stems 
such as “Next week I …” and “Things in general …”) found that while participants with pain, 
compared to those without pain, produced more negative health statements, they were not 
self-denigratory as would be expected in depression (see Morley et al. 2002). Diagnosis by 
interview uses the same symptom lists and priorities as do these inadequate measurement 
instruments and so does not offer a better alternative. This issue is associated with the 
increasing dissatisfaction with symptom count methods of diagnosis and the resulting 
heterogeneity of groups which have achieved the same total score, or exceeded the same 
cutpoint: there are 227 different ways to achieve the DSM-5 diagnosis of major depression 
(Galatzer-Levy and Bryant 2013). Recognition of the natural history of specific symptoms 
(Costello, 1983) and their association (or lack thereof) with persistent pain would enable 
theorists and researchers to build more specific models to address in psychological 
treatment. For example, there is increasing interest in the biological interactions of 
disturbed sleep and persistent pain, particularly fibromyalgia (Finan et al., 2013). Motivation 
to act, even in rewarding pursuits, is depleted in pain, in non-human animals as well as in 
humans, but in humans the fear of exacerbating pain or causing injury further lowers 
activity levels (Vlaeyen & Linton 2000). The cost of pain associated even with activities 
previously highly valued, including sexual activity, renders them no longer a source of 
pleasure and satisfaction (Williams, 1998). 
The main methodological problem with the studies included in this review was the use of 
measurement instruments for depression that were invalid, or whose validity was 
questionable, in a population with persistent pain. While the HADS remains the most 
suitable instrument, it is unsatisfactory because of its unstable factor structure (Coyne and 
van Sonderen 2012; Cosco et al. 2012). New measures will ideally arise from better models 
rather than from existing diagnostic taxonomies or symptom lists.  
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A further problem was that depression history was rarely assessed although this might help 
to identify the relationship between depression and persistent pain, as might a more 
detailed examination of cognitive bias and the content of depressive thinking. Further, 
depression and chronic pain can both fluctuate over time (Judd, 1997), which could be 
missed when assessed only at fixed time points. Gerrits et al. (2012) used a life chart 
assessment, which decreased the risk of missing out episodes of depression between 
baseline and follow-up; this or other measures that take into account such fluctuations over 
time could be used in future investigations. Additional methodological problems arose from: 
1) a lack of preregistration of trials (Bishop 2013), giving rise to the concern that some data 
analyses were not related to the original hypotheses for the study; and 2) the use of cut-off 
points to dichotomize data, a process which was not justified by the underlying models.  
 
Limitations of the current review 
We are aware of the risk that unpublished negative findings might exist but these could only 
make our already tentative findings more tentative, rather than reverse them. This review 
used one reviewer predominantly to conduct the search and to extract data from the 
studies; ideally, different reviewers should perform this procedure independently and 
discuss their findings, to minimize error or omissions.  
Further subjectivity was introduced by the content of the NOS quality scale (Stang 2010) and 
by its application by a single reviewer. We were aware that the quality assessment tool we 
used, like any such instrument, makes assumptions in its inclusions and exclusions, scoring, 
and weighting (Sanderson et al., 2007), and this is in part why we chose not to use the 
scores, except broadly, in interpreting findings. Ideally, criteria such as the minimum sample 
size in a study is not set by an arbitrary standard but are related to the statistical power of 
the study to detect the associations it investigates. Further, choice of statistical analysis was 
not included in the quality criteria but is an important question to ask of studies, particularly 
associational studies which may need to make statistical corrections for multiple 
comparisons. 
 
Implications  
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Depression or depressed mood is likely to add to the problems of people with persistent 
pain. Social problems may be a particular issue, often neglected in briefer pain management 
programs. Nor do the problems lie only with the person with pain. Where there is no 
medical evidence, people affected by persistent pain are stigmatized by others’ judgments 
of their motivation (De Ruddere et al. 2013), and their pain-related behaviors elicit adverse 
character judgements, although less so when observers deduce that these behaviors might 
be associated with pain (Ashton-James et al. 2014).  
None of the studies referenced a particular theory, even the otherwise commonly invoked 
diathesis-stress model; none even sampled diathesis factors, such as exposure to adverse 
experiences in childhood, nor did any focus on possible biological mechanisms in the 
development or progression of persistent pain and depression. There were few longitudinal 
studies overall, and cultural differences were overlooked. All these gaps remain to be 
explored.  
Psychological interventions for chronic pain, usually cognitive and behavioral therapy, vary 
considerably in content but often include intervention for depressed mood (more rarely for 
diagnosed depression). Depression or distress is commonly assessed as an outcome, with 
evidence that cognitive behavioral therapy (CBT) improves mood and catastrophizing 
outcomes (Williams et al. 2012). CBT for patients with persistent pain aims to change 
unhelpful patterns of thinking and behavior related to persistent pain, and includes 
components also used to treat depression, such as behavioral reactivation and targeting 
unhelpful beliefs and habits of thinking (Williams et al. 2012). Acceptance-based treatment 
for chronic pain may also produce improvements in depression and distress (Hunot et al. 
2013; Hann & McCracken 2014), even when it is not a direct target of treatment. Reviews of 
antidepressant drug interventions are disappointing (Chou et al., 2007; Urquhart et al., 
2008), but the combination of antidepressants with behavioral intervention is more 
promising (Kroenke et al., 2009). 
In a summary of the situation, Morley et al. (2013) concluded that the ‘signal to noise’ ratio 
was worsening in each successive meta-analysis of CBT for persistent pain, because of the 
proliferation of atheoretical, single-site, and often enthusiasm-driven randomized controlled 
trials available for meta-analysis. They proposed that trialists and clinicians should use the 
current evidence as a base on which to build more theoretically coherent studies of 
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populations selected on clinically relevant factors (not necessarily just the site of pain). It 
would be valuable to see treatment of chronic pain stratified by severity of depression and 
designed to address pain in the context of mood problems. In depressed patients, treatment 
would directly address hopelessness about making treatment gains, difficulties with 
motivation to practice new behaviours, often impoverished relationships and social 
contacts, and poor sleep quality. 
Many people with chronic pain, however, receive more physical or medical treatment, and a 
systematic review of moderators (Gurung et al. 2015) suggested that those with significant 
anxiety or depression at baseline made greater gains from these treatments, but that the 
change is in function, not depression, and furthermore it is not clear that this change is 
sustained beyond the end of treatment. Many trials, and physical therapy-based pain 
services, exclude or find it hard to retain people with psychological needs if their health care 
staff lack specific training (Main et al., 2012), so the prospects for depressed patients 
seeking chronic pain treatment outside trials is currently poor. The application of specific 
guidance, such as that by Dowrick (2015) for working in primary care with patients with 
depressive symptoms, would substantially improve the situation for patients with persistent 
pain and depressed mood, and enable patient and doctor to share the construction of a 
treatment model. 
 
Conclusion 
Overall, this review has identified a very small body of evidence that depression at baseline 
is associated with worse outcomes in persistent pain; we were unable to find any reliable 
evidence with which to provide answers to our other questions. Clearer tests of existing 
models, and development of models which relate more closely to patients’ experiences and 
to social and cultural contexts, would advance the field. Arguably, social and behavioral 
findings from animal models are underused, but much could be gained by careful 
elaboration of each cognitive, emotional or behavioral problem associated with the 
complaint of depression (Costello 1983), and the ways in which each interacts with other 
health problems, such as chronic pain. 
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The current monolithic models of depression serve the field poorly. Depression may be far 
better understood as multiple disorders with some overlap of symptoms (Blackburn-Monro 
and Blackburn-Monro 2001) which nevertheless have their own natural histories and 
different responses to treatment (Costello 1983). The new DSM-5 (American Psychiatric 
Association 2013), while it moves away at last from the diagnosis of psychological disorder 
by exclusion of medical evidence characteristic of previous versions (and of other diagnostic 
systems), still pathologizes what many clinicians and researchers consider to be problems of 
adaptation to persistent medical problems with widespread adverse effects on the 
individual (Katz et al. 2015). It continues to rely on notions of ‘excess’ or ‘disproportionate’ 
responses by the individual to his or her illness, as if there is a universally agreed correct 
quality and quantity of response. This injudicious wording may contribute significantly to 
the unreliability of the DSM-5 diagnosis of somatic symptom disorder (Katz et al. 2015).  
Overall, this review was able to tell us relatively little about the effect of depression on 
untreated chronic pain, or untreated chronic pain on depression. Future longitudinal studies 
of the interaction of pain and depression will ideally be pre-registered and adequately 
powered; will use appropriate measures (including less psychometrically standard ones, 
such as that in Pincus et al. (2007) and Rusu et al. (2012)); will characterize the depression 
history of participants at baseline; will take multiple measures over the course of the study, 
i.e. not only at baseline and at a single endpoint; and will include some of the important 
variables used in the mediation studies reviewed above (see also Ehde et al. 2014) and 
possibly use their more sophisticated statistical modeling. The findings of such studies 
should help to resolve the current inconsistent judgments across chronic pain treatment 
about whether people with diagnosable depression are suitable for such treatment (Morley 
and Williams 2006), resulting in the exclusion of many people with persistent pain and 
unreliably diagnosed depression who might well benefit from pain treatment. 
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Table 1. Details of included studies 
 
Author (Year) 
Country 
Quality 
score /8 
Recruitment 
method 
 
Data collection  
 
Population 
 
 
Mean (SD) age 
in years; range 
Sample 
size  
(n male) 
Time from baseline to 
follow-up(s) 
 
Outcome of depression in chronic pain  
Dunn et al. (2008) 
UK 
7 Postal survey Self report 
questionnaire 
Patients with low back pain 47 (8),  
30 - 59  
426 (188)  12 months 
Hurwitz et al. 
(2003) 
USA 
6 Postal survey Self report 
questionnaire 
Patients with back pain  
 
51 (17), 
 NP 
681 (327) 2 weeks, 6 weeks, 6, 
12 and 18 months 
Kroenke et al. 
(2012) 
USA 
7 Clinic visit Clinical interview Patients with chronic low 
back, hip or knee pain – 
127/250 depressed  
56 (11),  
NP 
377 (187) 3 months, 6 months 
and 12 months 
Muller et al. 
(2013) 
UK 
7 Primary care 
consultations 
 
Self report 
questionnaire 
Patients with chronic pain 65 (10), >50 329 (126) 12 months 
 
Ryall et al. (2007) 
UK 
6 Primary care 
consultations 
Self-report 
questionnaire 
Clinical 
assessment 
Telephone 
interview  
Patients with chronic arm 
pain 
 
NP,  
15 - 64 
313 (127) 1 month, 3 months, 6 
months and 12 
months 
Von Korff et al. 
(2005) 
USA 
6 Primary care 
consultation 
Telephone 
interview 
Patients with chronic back 
pain 
 
NP,  
18 - 75 
1213 (600) 1, 2 and 5 years 
 
Outcome of chronic pain in depression  
Chung et al. 
(2012) 
Hong Kong 
6 Clinic visit Clinical interview Patients diagnosed with 
major depressive disorder 
48 (10) 
18 – 65 
82 (18) 3 months 
Gerrits et al. 5 Postal Clinical interview,  Patients with depressive 42 (12),  1209 (531) 24 months 
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(2012) 
Netherlands 
questionnaire  self-report 
questionnaire 
and/or anxiety disorder  
 
NP 
Kroenke et al. 
(2008) 
USA 
5 Clinic visit Clinical interview, 
telephone 
interview at 
follow-up 
Patients with a diagnosis of 
depression 
 
42 (NP), NP 405 (81) 3 months and 6 
months  
 
 
Studies of mediation by other variables 
Lerman et al. 
(2012) 
Israel 
4 Clinic visit 
 
 
Self-report 
questionnaire 
Telephone 
interview 
Patients with chronic pain 
Mediators:  
Self-criticism 
Sex 
Affective pain 
Sensory pain 
Outcome: depression 
57 (14),  
19 - 90 
163 (61) Mean 4.34 months 
(range 2-8 months) 
McCracken and 
Eccleston (2005) 
UK 
4 Clinic visit Clinical 
assessment 
Patients with chronic pain 
Mediators:  
Pain acceptance (activity 
engagement, pain 
willingness) 
Outcome variables: pain, 
depression 
44 (11),  
NP 
118 (NP) Mean 3.9 months  
McCracken et al. 
(2007) 
UK 
4 Clinic visit Clinical 
assessment 
Patients with chronic pain 
Pain coping strategies:  
Pain management 
Pain control 
Help seeking 
Activity persistence  
Outcome variables: pain, 
depression 
45 (11),  
NP 
115 (53) Mean 3.7 months  
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Rudich et al. 
(2010) 
Israel 
3 Waiting for first 
pain specialist 
consultation 
Questionnaire 
Medical 
assessment 
Patients with chronic pain 
Mediators:  
Physician prognosis 
Self-criticism 
Sex 
Age 
Sensory Pain; Affective pain 
Outcome variable: 
depression 
58 (13),  
24 - 81 
45 (19) Mean 5 months 
(range 2-8 months) 
Van Liew et al. 
(2013) 
USA 
5 Advertisements 
in newspapers 
and physician 
offices, 
referrals by 
physicians 
Questionnaire Patients with fibromyalgia 
syndrome (majority female)  
Mediators:  
Physical functioning 
Self-efficacy 
Outcome variables: pain, 
depression 
54 (11),  
NP 
462 (20) 6 months, 12 months 
Velly et al. (2011) 
USA 
6 Advertisements 
in dental 
surgeries 
 
Clinical 
examination 
Questionnaire 
Patients with chronic 
temporomandibular joint 
pain  
Mediators:  
Catastrophising 
Sex 
Age  
Outcome: Progression to 
clinically significant pain 
37 (12),  
NP 
480 (276) 18 months 
NP Not provided 
 
 
